Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel S Key

Showing results (61-70 of 255) with videos related to

Pageof 26
Sort By:
American Journal of Preventive Medicine|March 25, 2010
Complications associated with carrier status among people with blood disorders: a commentaryW Craig Hooper, Connie H Miller, Nigel S Key
Transfusion|March 27, 2004
Measurement of bleeding severity: a critical reviewRachel Koreth, Craig Weinert, Daniel J Weisdorf, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2010
Venous thromboembolism in multiple myeloma: current perspectives in pathogenesisNoppacharn Uaprasert, Peter M Voorhees, Nigel Mackman, et al.
Haematologica|October 4, 2024
Adverse clinical outcomes associated with sickle cell trait at high altitudeKatherine A Stafford, Soravis Osataphan, Rushad Patell, et al.
Thrombosis and Haemostasis|August 3, 2002
Possible synergy between recombinant factor VIIa and prothrombin complex concentrate in hemophilia therapyNigel S Key, Beverly Christie, Nicole Henderson, et al.
Thrombosis Research|May 4, 2010
Membrane microparticles in VTE and cancerNigel S Key, Pichika Chantrathammachart, Patrick W Moody, et al.
Thrombosis Research|May 25, 2010
African-Americans have a higher rate of proximal deep vein thrombosis at presentationTyler W Buckner, Chirag Amin, Denise A Esserman, et al.
Thrombosis Research|June 5, 2012
Studies on the mechanism of action of the aptamer BAX499, an inhibitor of tissue factor pathway inhibitorJen-Yea Chang, Pichika Chantrathammachart, Dougald M Monroe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 10, 2025
F8 Variants and Inhibitor Development in a Multiethnic Cohort of Nonsevere Haemophilia AMing Y Lim, Kristy Lee, Jill M Johnsen, et al.
Thrombosis and Haemostasis|February 19, 2002
Is homozygosity for the HR2 haplotype a risk factor for venous thromboembolism?Omer Aras, Naomi Q Hanson, Michael Y Tsai, et al.
Pageof 26

Showing results (61-70 of 255) with videos related to

Sort By:
Pageof 26
American Journal of Preventive Medicine|March 25, 2010
Complications associated with carrier status among people with blood disorders: a commentaryW Craig Hooper, Connie H Miller, Nigel S Key
Transfusion|March 27, 2004
Measurement of bleeding severity: a critical reviewRachel Koreth, Craig Weinert, Daniel J Weisdorf, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2010
Venous thromboembolism in multiple myeloma: current perspectives in pathogenesisNoppacharn Uaprasert, Peter M Voorhees, Nigel Mackman, et al.
Haematologica|October 4, 2024
Adverse clinical outcomes associated with sickle cell trait at high altitudeKatherine A Stafford, Soravis Osataphan, Rushad Patell, et al.
Thrombosis and Haemostasis|August 3, 2002
Possible synergy between recombinant factor VIIa and prothrombin complex concentrate in hemophilia therapyNigel S Key, Beverly Christie, Nicole Henderson, et al.
Thrombosis Research|May 4, 2010
Membrane microparticles in VTE and cancerNigel S Key, Pichika Chantrathammachart, Patrick W Moody, et al.
Thrombosis Research|May 25, 2010
African-Americans have a higher rate of proximal deep vein thrombosis at presentationTyler W Buckner, Chirag Amin, Denise A Esserman, et al.
Thrombosis Research|June 5, 2012
Studies on the mechanism of action of the aptamer BAX499, an inhibitor of tissue factor pathway inhibitorJen-Yea Chang, Pichika Chantrathammachart, Dougald M Monroe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 10, 2025
F8 Variants and Inhibitor Development in a Multiethnic Cohort of Nonsevere Haemophilia AMing Y Lim, Kristy Lee, Jill M Johnsen, et al.
Thrombosis and Haemostasis|February 19, 2002
Is homozygosity for the HR2 haplotype a risk factor for venous thromboembolism?Omer Aras, Naomi Q Hanson, Michael Y Tsai, et al.
Pageof 26